Pharmarise Holdings Corporation (TYO:2796)
501.00
0.00 (0.00%)
Jun 19, 2026, 3:30 PM JST
Pharmarise Holdings Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
| 5,763 | 5,510 | 7,252 | 5,759 | 6,809 | 7,211 | |
Market Cap Growth | 3.31% | -24.02% | 25.92% | -15.42% | -5.58% | 16.98% |
Enterprise Value | 18,210 | 17,564 | 12,732 | 10,202 | 12,910 | 13,929 |
Last Close Price | 501.00 | 472.28 | 610.25 | 560.02 | 652.59 | 680.87 |
PE Ratio | - | - | - | 17.29 | 15.23 | 16.93 |
Forward PE | - | 7.30 | 7.30 | 7.30 | 7.30 | 7.30 |
PS Ratio | 0.09 | 0.09 | 0.13 | 0.11 | 0.13 | 0.14 |
PB Ratio | 0.86 | 0.80 | 0.98 | 0.82 | 1.02 | 1.14 |
P/TBV Ratio | 192.09 | - | 7.71 | 1.59 | 2.29 | 4.11 |
P/FCF Ratio | - | 8.18 | 3.24 | 2.69 | 20.39 | 5.02 |
P/OCF Ratio | - | 4.20 | 2.67 | 2.29 | 9.55 | 3.71 |
EV/Sales Ratio | 0.27 | 0.28 | 0.23 | 0.20 | 0.25 | 0.27 |
EV/EBITDA Ratio | 7.21 | 9.82 | 6.10 | 3.83 | 4.56 | 5.38 |
EV/EBIT Ratio | 23.02 | 59.54 | 13.90 | 7.09 | 8.49 | 11.17 |
EV/FCF Ratio | - | 26.06 | 5.68 | 4.77 | 38.65 | 9.69 |
Debt / Equity Ratio | 2.19 | 2.07 | 1.71 | 1.31 | 1.48 | 1.69 |
Debt / EBITDA Ratio | - | 7.99 | 6.11 | 3.43 | 3.50 | 4.13 |
Debt / FCF Ratio | - | 21.19 | 5.69 | 4.27 | 29.68 | 7.44 |
Net Debt / Equity Ratio | 1.85 | 1.36 | 0.75 | 0.63 | 0.88 | 0.96 |
Net Debt / EBITDA Ratio | 4.92 | 5.24 | 2.68 | 1.65 | 2.09 | 2.35 |
Net Debt / FCF Ratio | - | 13.90 | 2.50 | 2.05 | 17.73 | 4.24 |
Asset Turnover | 2.16 | 2.07 | 2.06 | 2.21 | 2.13 | 2.10 |
Inventory Turnover | 12.40 | 16.06 | 18.65 | 19.12 | 17.79 | 16.92 |
Quick Ratio | 0.49 | 0.73 | 1.00 | 0.89 | 0.97 | 0.82 |
Current Ratio | 0.93 | 1.10 | 1.29 | 1.16 | 1.28 | 1.12 |
Return on Equity (ROE) | - | -5.29% | -4.74% | 5.07% | 7.02% | 6.84% |
Return on Assets (ROA) | - | 0.60% | 2.16% | 3.81% | 3.92% | 3.12% |
Return on Invested Capital (ROIC) | 4.42% | -76.46% | -17.94% | 3.97% | 4.20% | 3.47% |
Return on Capital Employed (ROCE) | 4.20% | 1.50% | 4.90% | 10.60% | 10.00% | 8.10% |
Earnings Yield | -1.87% | -6.66% | -4.84% | 5.78% | 6.57% | 5.91% |
FCF Yield | - | 12.23% | 30.92% | 37.16% | 4.91% | 19.93% |
Dividend Yield | 2.79% | 2.96% | 2.29% | 2.50% | 2.15% | 2.06% |
Payout Ratio | - | - | - | 39.34% | 29.31% | 30.28% |
Buyback Yield / Dilution | -1.85% | -7.58% | 15.61% | -0.59% | -0.20% | 1.03% |
Total Shareholder Return | 0.94% | -4.61% | 17.90% | 1.91% | 1.95% | 3.08% |